Cargando…

Safety Profile of Linezolid in Older Adults With Renal Impairment: A Population-Based Retrospective Cohort Study

BACKGROUND: The objective of this study was to characterize the safety profile of linezolid in patients with renal impairment compared with patients without renal impairment. METHODS: A population-based retrospective cohort study using linked administrative databases included patients aged 66 years...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bai, Anthony D, McKenna, Susan, Wise, Heather, Loeb, Mark, Gill, Sudeep S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801225/ https://www.ncbi.nlm.nih.gov/pubmed/36601560 http://dx.doi.org/10.1093/ofid/ofac669

Ejemplares similares

Association of Linezolid With Risk of Serotonin Syndrome in Patients Receiving Antidepressants
por: Bai, Anthony D., et al.
Publicado: (2022)

Safety and Outcomes of Linezolid Use for Nocardiosis
por: Davidson, Natalie, et al.
Publicado: (2020)

Clinical Outcomes Associated With Linezolid Resistance in Leukemia Patients With Linezolid-Resistant Staphylococcus epidermidis Bacteremia
por: Folan, Stephanie A, et al.
Publicado: (2018)

Low-Dose Linezolid for Treatment of Patients With Multidrug-Resistant Tuberculosis
por: Mase, Anjeli, et al.
Publicado: (2022)

Bedaquiline, Delamanid, Linezolid, and Clofazimine for Treatment of Pre-extensively Drug-Resistant Tuberculosis
por: Padmapriyadarsini, Chandrasekaran, et al.
Publicado: (2022)

Clindamycin Plus Vancomycin Versus Linezolid for Treatment of Necrotizing Soft Tissue Infection
por: Dorazio, Joshua, et al.
Publicado: (2023)

Risk Factors and Outcomes Associated With Acquisition of Daptomycin and Linezolid–Nonsusceptible Vancomycin-Resistant Enterococcus
por: Greene, Matthew H, et al.
Publicado: (2018)

A Cross-sectional Analysis of Linezolid in Combination with Methadone or Buprenorphine as a Cause of Serotonin Toxicity
por: Traver, Edward C, et al.
Publicado: (2022)

A Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, With or Without Aspirin, for Human Immunodeficiency Virus–Associated Tuberculous Meningitis: The LASER-TBM Trial
por: Davis, Angharad G, et al.
Publicado: (2022)

Pharmacodynamic Correlates of Linezolid Activity and Toxicity in Murine Models of Tuberculosis
por: Bigelow, Kristina M, et al.
Publicado: (2020)

Proposed Linezolid Dosing Strategies to Minimize Adverse Events for Treatment of Extensively Drug-Resistant Tuberculosis
por: Imperial, Marjorie Z, et al.
Publicado: (2021)

Proposal of initial and maintenance dosing regimens with linezolid for renal impairment patients
por: Kawasuji, Hitoshi, et al.
Publicado: (2021)

Sensitivity and Specificity of Procalcitonin in Predicting Bacterial Infections in Patients With Renal Impairment
por: El-sayed, Dena, et al.
Publicado: (2014)

Prevalence and Evolution of Renal Impairment in People Living With HIV in Rural Tanzania
por: Mapesi, Herry, et al.
Publicado: (2018)

An examination of entrance criteria for international medical graduates (IMGs) into Canadian psychiatry residency programs
por: Soma, Ashok, et al.
Publicado: (2017)

The safety profile of COVID-19 vaccinations in the United States
por: Singh, Amninder, et al.
Publicado: (2022)

Antibiotic Prescribing in New York State Medicare Part B Beneficiaries Diagnosed With Cystitis Between 2016 and 2017
por: Yu, Joyce Y, et al.
Publicado: (2020)

Effectiveness, safety, and cost of vancomycin and linezolid in Kuwait: A retrospective cohort study
por: Alghanem, Sarah S., et al.
Publicado: (2023)

Real-World Experience With Higher-Than-Recommended Doses of Lamivudine in Patients With Varying Degrees of Renal Impairment
por: Fischetti, Briann, et al.
Publicado: (2018)

Renal Safety of Long-term Tenofovir Disoproxil Fumarate Treatment in Patients With Chronic Hepatitis B
por: Woldemedihn, Gezahegn M, et al.
Publicado: (2023)

HIV-Infected Individuals on ART With Impaired Immune Recovery Have Altered Plasma Metabolite Profiles
por: Nyström, Sofia, et al.
Publicado: (2021)

Lactic acidosis associated with standard dose linezolid in a kidney recipient with impaired renal function
por: Chen, Chien-Chou, et al.
Publicado: (2021)

Matched Cohort Study of Convalescent COVID-19 Plasma Treatment in Severely or Life Threateningly Ill COVID-19 Patients
por: Klapholz, Marc, et al.
Publicado: (2021)

Safety and Effectiveness of High-Dose Cefazolin in Patients With High Body Weight: A Retrospective Cohort Study
por: Ryu, HaYoung, et al.
Publicado: (2022)

Safety of long-term use of linezolid: results of an open-label study
por: Vazquez, Jose A, et al.
Publicado: (2016)

Frailty Is Associated With Increased Hemagglutination-Inhibition Titers in a 4-Year Randomized Trial Comparing Standard- and High-Dose Influenza Vaccination
por: Loeb, Nathalie, et al.
Publicado: (2020)

Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Patients With HIV-1 Infection and Ongoing Substance Use Disorder: The BASE Study
por: Havens, Joshua P, et al.
Publicado: (2023)

Safety of Outpatient Parenteral Antimicrobial Therapy in Nonagenarians
por: Shrestha, Nabin K, et al.
Publicado: (2020)

Renal Impairment, C. difficile Recurrence, and the Differential Effect of Bezlotoxumab: A Post Hoc Analysis of Pooled Data From 2 Randomized Clinical Trials
por: Golan, Yoav, et al.
Publicado: (2020)

Safety of linezolid in patients with decreased renal function and trough monitoring: a systematic review and meta-analysis
por: Liu, Xiaoxi, et al.
Publicado: (2022)

Efficacy and Safety of Cefmetazole for Bacteremia Caused by Extended-Spectrum β-Lactamase–Producing Enterobacterales vs Carbapenems: A Retrospective Study
por: Kashihara, Eriko, et al.
Publicado: (2023)

Safety and Efficacy of Submuscular Implantation With Resterilized Cardiac Implantable Electronic Device in Patients With Device Infection: A Retrospective Observational Study in Taiwan
por: Yu, Chia-Meng, et al.
Publicado: (2022)

Retrospective Analysis of the Safety and Efficacy of Fecal Microbiota, Live-jslm (REBYOTA(TM)) Administered Under Enforcement Discretion to Patients With Clostridioides difficile Infection
por: Feuerstadt, Paul, et al.
Publicado: (2023)

Varicella Virus Vaccine Live: A 22-Year Review of Postmarketing Safety Data
por: Woodward, Meredith, et al.
Publicado: (2019)

Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial
por: Leroux-Roels, Isabel, et al.
Publicado: (2022)

Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 Study
por: Brown, Michelle L, et al.
Publicado: (2020)

Cognitive Impairment in Tuberculous Meningitis
por: Davis, Angharad G, et al.
Publicado: (2022)

The Efficacy and Safety of Linezolid and Glycopeptides in the Treatment of Staphylococcus aureus Infections
por: Fu, Jinjian, et al.
Publicado: (2013)

Clinical efficacy and safety of linezolid in intensive care unit patients
por: Ma, Aijia, et al.
Publicado: (2022)

Low Rate of Acquired Linezolid Resistance in Multidrug-Resistant Tuberculosis Treated With Bedaquiline-Linezolid Combination
por: Du, Jian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1te37gpitvc0uqk278gq76dij7